Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of July 23, 2025 • 2:21 PM ET

Date/Time Source News Release
07/15/2025 07:30 AM EDT GlobeNewswire Plus Therapeutics Presents ReSPECT-LM Clinical Trial Results for REYOBIQ(TM) in Patients with Leptomeningeal Metastases
07/10/2025 07:30 AM EDT GlobeNewswire Plus Therapeutics Announces Two CNSide Presentations at the Upcoming SNO/ASCO CNS Metastases Conference
07/08/2025 07:30 AM EDT GlobeNewswire Plus Therapeutics Announces Initial Patients Successfully Treated in ReSPECT-LM Dose Optimization Trial for REYOBIQ(TM) in Leptomeningeal Metastases
06/30/2025 07:30 AM EDT GlobeNewswire Plus Therapeutics Announces FDA Agreement to Initiate ReSPECT-LM Dose Optimization Trial for REYOBIQ(TM) in Leptomeningeal Metastases
06/26/2025 07:30 AM EDT GlobeNewswire Plus Therapeutics Provides Business Update on CNSide Diagnostics Subsidiary
06/25/2025 04:15 PM EDT GlobeNewswire Plus Therapeutics to Provide Business Update and Host Conference Call on Thursday, June 26, 2025 at 9:00 A.M. ET
06/25/2025 07:30 AM EDT GlobeNewswire Plus Therapeutics Announces FDA Clearance of its Investigational New Drug Application using REYOBIQTM for the Treatment of Childhood Brain Cancer
06/24/2025 07:30 AM EDT GlobeNewswire Plus Therapeutics Announces Comprehensive Restructuring of $15 Million March 2025 Equity Financing
05/30/2025 04:15 PM EDT GlobeNewswire Plus Therapeutics Reports First Quarter Financial Results and Recent Business Highlights
05/23/2025 04:15 PM EDT GlobeNewswire Plus Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q
Page

Additional News

As of July 23, 2025 • 2:21 PM ET

Date/Time Source News Release
07/23/2025 07:41 AM EDT SeekingAlpha Plus Therapeutics announces $1.6 million advance payment from CPRIT
06/25/2025 02:00 PM EDT PRISM News PRISM Mid-Day Movers: FDA Clearance and Positive Trial Data Drive Gains
06/25/2025 01:05 PM EDT AllPennyStocks.com Biotech Continues This Week's Momentum With Another Key Announcement
06/25/2025 10:35 AM EDT 24/7 Market News Top Stocks to Watch: June 25, 2025 Edition
06/25/2025 09:45 AM EDT SeekingAlpha Plus Therapeutics rises after FDA clearance to begin Reyobiqtm trial
06/25/2025 09:32 AM EDT 24/7 Market News Plus Therapeutics Receives FDA Clearance for REYOBIQ Pediatric Brain Cancer Trial
06/19/2025 12:00 PM EDT Zacks Plus (PSTV) Upgraded to Buy: Here's Why
06/18/2025 02:00 PM EDT PRISM News PRISM Mid-Day Movers: Stock Dilution and Cannabis Earnings Drive Indices Lower
06/18/2025 07:32 AM EDT SeekingAlpha Plus Therapeutics drops 5%, files prospectus for 17M share secondary offering
06/02/2025 12:31 AM EDT SeekingAlpha Plus Therapeutics GAAP EPS of -$1.19 misses by $0.97, revenue of $1.06M misses by $0.08M
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.